Literature DB >> 18083013

Executive deficits in psychotic and bipolar disorders - implications for our understanding of schizoaffective disorder.

Andrei Szoke1, Alexandre Meary, Anca Trandafir, Frank Bellivier, Isabelle Roy, Franck Schurhoff, Marion Leboyer.   

Abstract

OBJECTIVE: Schizoaffective disorder could be considered as a form of schizophrenia, a form of bipolar disorder, an independent disorder or a disorder intermediate between bipolar disorder and schizophrenia, within a psychotic continuum. The study of cognitive deficits in subjects with those diagnoses could help differentiate between these possibilities.
METHODS: We compared cognitive performances of schizoaffective (SZAff) subjects with those of subjects with schizophrenia (SZ), bipolar disorder with psychotic symptoms (life-time) (BDP), bipolar disorder without life-time occurrence of psychotic symptoms (BD) and normal controls (NC). We used two tests of executive functions - the Wisconsin Card Sorting Test (WCST) and the Trail-making Test (TMT) - that are known to be impaired in those disorders.
RESULTS: The number of perseverative errors on WCST was highest in SZ subjects and gradually decreased in SZAff, BDP and, finally in BD subjects. By contrast, SZ and SZAff subjects obtained similar scores in the TMT, as did BD and BDP patients.
CONCLUSIONS: These results suggest that, for some deficits, there may be a continuum between SZ, SZAff and affective disorders, whereas SZAff patients most closely resemble SZ patients for other deficits. This implies that different conceptual views about schizoaffective disorder should be seen as complementary, rather than mutually exclusive.

Entities:  

Mesh:

Year:  2007        PMID: 18083013     DOI: 10.1016/j.eurpsy.2007.10.006

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  24 in total

1.  Association of common variants in H2AFZ gene with schizophrenia and cognitive function in patients with schizophrenia.

Authors:  Ming Chang; Linyan Sun; Xinmei Liu; Wei Sun; Xuqun You
Journal:  J Hum Genet       Date:  2015-08-06       Impact factor: 3.172

Review 2.  Schizoaffective disorder: a review of current research themes and pharmacological management.

Authors:  Joshua T Kantrowitz; Leslie Citrome
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

3.  Examining cognition across the bipolar/schizophrenia diagnostic spectrum.

Authors:  Amy J Lynham; Leon Hubbard; Katherine E Tansey; Marian L Hamshere; Sophie E Legge; Michael J Owen; Ian R Jones; James T R Walters
Journal:  J Psychiatry Neurosci       Date:  2018-04-05       Impact factor: 6.186

4.  Patient-centered care in affective, non-affective, and schizoaffective groups: patients' opinions and attitudes.

Authors:  Raymond Tempier; Shelanne L Hepp; C Randy Duncan; Betty Rohr; Krystal Hachey; Karen Mosier
Journal:  Community Ment Health J       Date:  2010-05-18

5.  Examining cognition across the bipolar/schizophrenia diagnostic spectrum.

Authors:  Amy J Lynham; Leon Hubbard; Katherine E Tansey; Marian L Hamshere; Sophie E Legge; Michael J Owen; Ian R Jones; James T R Walters
Journal:  J Psychiatry Neurosci       Date:  2018-07       Impact factor: 6.186

6.  Infusions of Nerve Growth Factor Into the Developing Frontal Cortex Leads to Deficits in Behavioral Flexibility and Increased Perseverance.

Authors:  Sagar J Desai; Brian L Allman; Nagalingam Rajakumar
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

7.  Profile and Determinants of Disability in Psychotic Disorders in Nigeria.

Authors:  Victor Olufolahan Lasebikan; Olatunde Ayinde
Journal:  Community Ment Health J       Date:  2016-12-01

8.  Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group.

Authors:  Carmen Simonsen; Kjetil Sundet; Anja Vaskinn; Astrid B Birkenaes; John A Engh; Ann Faerden; Halldóra Jónsdóttir; Petter Andreas Ringen; Stein Opjordsmoen; Ingrid Melle; Svein Friis; Ole A Andreassen
Journal:  Schizophr Bull       Date:  2009-05-14       Impact factor: 9.306

9.  Cognitive impairment in affective psychoses: a meta-analysis.

Authors:  Emre Bora; Murat Yücel; Christos Pantelis
Journal:  Schizophr Bull       Date:  2009-09-18       Impact factor: 9.306

10.  Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.

Authors:  S Kristian Hill; James L Reilly; Richard S E Keefe; James M Gold; Jeffrey R Bishop; Elliot S Gershon; Carol A Tamminga; Godfrey D Pearlson; Matcheri S Keshavan; John A Sweeney
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.